In this Q&A, Jenna DiRito, PhD, COO and co-founder of Revalia Bio, discusses how earlier, human-relevant data is reshaping go ...
In this video interview, Mwango Kashoki, MD, MPH, senior vice president and global head of regulatory strategy at Parexel, ...
In today's ACT Brief, we explore how FDA evaluates effectiveness for ultra-rare individualized therapies, the agency's ...
1. FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results. News release. FDA. April 13, 2026.
In today's ACT Brief, we examine how protocol interpretation and source document preparation delay study startup, how the ...
In this video interview, Mwango Kashoki, MD, MPH, senior vice president and global head of regulatory strategy at Parexel, ...
A collaborative study by the Tufts Center for the Study of Drug Development and CRIO identifies protocol interpretation and source document preparation as an understudied yet significant bottleneck in ...
In today's ACT Brief, we examine Thermo Fisher's expanded real-world data access through HealthVerity, how FHIR-based ...
In a recent video interview with Applied Clinical Trials, Mwango Kashoki, MD, MPH, senior vice president and global head of ...
A collaborative study by the Tufts Center for the Study of Drug Development and CRIO identifies protocol interpretation and ...
In today's ACT Brief, we explore industry perspectives on operational and methodological shifts defining 2026, how agentic AI ...
In a recent video interview with Applied Clinical Trials, Nick Frenzer, general manager of site solutions at Veeva Systems, discussed why eSource has remained c ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results